Source: Eur Respir J 2003; 21: 611-615
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Meert A-P., Verdebout J-M., Martin B., Ninane V., Feoli F., Sculier J-P.. Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions. Eur Respir J 2003; 21: 611-615

Member's Comments

No comment yet.

Related content which might interest you: Stage IV adenocarcinoma of the lung with classical epidermal growth factor receptor mutation and a thought-provoking course Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Source: Eur Respir J 2008; 32: 924-930 Year: 2008 Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer Source: Eur Respir J 2011; 37: 183-193 Year: 2011 Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer Source: Eur Respir J 2005; 25: 329-335 Year: 2005 EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up Source: Eur Respir J 2009; 33: 436-440 Year: 2009 Angiogenesis in preinvasive, early invasive bronchial lesions and micropapillomatosis and correlation with EGF-R expression Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity Year: 2006 Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas Source: Eur Respir Rev 2014; 23: 356-366 Year: 2014 Prognostic significance of epidermal growth factor receptor expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Source: Eur Respir J 2013; 41: 417-424 Year: 2013 Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung cancer and its correlation with survival Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor Source: Eur Respir J 2008; 31: 714-724 Year: 2008 The prognostic value of serum epidermal growth factor receptor (EGFR) levels in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Characteristics of common and uncommon epidermal growth factor receptros gene mutations in patients with non small cell lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non small cell lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Clinical features associated with epidermal growth factor receptor and K-RAS gene mutations in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 811s Year: 2006 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 A blood-based test for epidermal growth factor receptor mutations in patients with non-small cell lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008